Entering text into the input field will update the search result below

SIGA says got orders worth about $28M for smallpox/monkeypox treatment TPOXX

Jul. 12, 2022 4:27 PM ETSIGA Technologies, Inc. (SIGA)By: Anuron Mitra, SA News Editor

Monkeypox virus test results document with stethoscope

Bill Oxford

  • SIGA Technologies (NASDAQ:SIGA) on Tuesday said it had got orders worth about $28M for its oral smallpox treatment TPOXX (tecovirimat).
  • TPOXX was approved as a treatment for smallpox by the U.S. FDA in 2018 and Canada's drug regulator

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About SIGA

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SIGA Technologies, Inc.
Edgewise Therapeutics, Inc.
Oculis Holding AG
GH Research PLC
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.